59 tracked 13F filers disclose a position in PRLD as of the latest SEC 13F filings, a combined $127.2M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | $37.3M | 10.9M | —Held | Q1 2026 | |
| 2 | BAKER BROS. ADVISORS LP | $34.6M | 10.1M | —Held | Q1 2026 | |
| 3 | Soleus Capital Management, L.P. | $18.0M | 3.4M | ▲New +3.4M sh | Q2 2026 | |
| 4 | Kynam Capital Management, LP | $5.4M | 1.6M | ▲+102% Added · +804K sh | Q1 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $4.2M | 1.2M | →First observed position No prior filed position | Q1 2026 | |
| 6 | EcoR1 Capital, LLC | $3.2M | 947K | ▲New +947K sh | Q1 2026 | |
| 7 | TWO SIGMA INVESTMENTS, LP | $3.2M | 924K | ▲+17% Added · +135K sh | Q1 2026 | |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | $4.5M | 842K | ▲+178% Added · +539K sh | Q2 2026 | |
| 9 | SPHERA FUNDS MANAGEMENT LTD. | $1.9M | 558K | ▲+355% Added · +436K sh | Q1 2026 | |
| 10 | STATE STREET CORP | $2.3M | 429K | ▲+210% Added · +291K sh | Q2 2026 | |
| 11 | MILLENNIUM MANAGEMENT LLC | $1.3M | 383K | ▲+153% Added · +232K sh | Q1 2026 | |
| 12 | MARSHALL WACE, LLP | $1.2M | 359K | ▲+31% Added · +85K sh | Q1 2026 | |
| 13 | MORGAN STANLEY | $1.1M | 322K | ▼−3.8% Reduced · −13K sh | Q1 2026 | |
| 14 | BlackRock, Inc. | $1.1M | 322K | ▲+21% Added · +56K sh | Q1 2026 | |
| 15 | RENAISSANCE TECHNOLOGIES LLC | $941K | 275K | ▲+1.4% Added · +4K sh | Q1 2026 | |
| 16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $916K | 268K | ▲+97% Added · +132K sh | Q1 2026 | |
| 17 | GOLDMAN SACHS GROUP INC | $809K | 236K | ▲+101% Added · +119K sh | Q1 2026 | |
| 18 | JANE STREET GROUP, LLC | $660K | 193K | ▲+74% Added · +82K sh | Q1 2026 | |
| 19 | VANGUARD FIDUCIARY TRUST CO | $538K | 157K | →First observed position No prior filed position | Q1 2026 | |
| 20 | ADAR1 Capital Management, LLC | $523K | 153K | ▲New +153K sh | Q1 2026 | |
| 21 | Connor, Clark & Lunn Investment Management Ltd. | $669K | 126K | ▲+15% Added · +17K sh | Q2 2026 | |
| 22 | CITADEL ADVISORS LLC | $425K | 124K | ▲New +124K sh | Q1 2026 | |
| 23 | UBS Group AG | $221K | 65K | ▲35× Added · +63K sh | Q1 2026 | |
| 24 | XTX Topco Ltd | $196K | 57K | ▲+14% Added · +7K sh | Q1 2026 | |
| 25 | BANK OF AMERICA CORP /DE/ | $193K | 57K | ▲+476% Added · +47K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 14 funds opened a new position in PRLD and 8 added to an existing one, while 3 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 25 funds | $5.3B |
| BRISTOL-MYERS SQUIBB COBMY | 24 funds | $2.1B |
| CULLINAN THERAPEUTICS INCCGEM | 24 funds | $108.1M |
| UNITEDHEALTH GROUP INCUNH | 23 funds | $2.9B |
| BIOGEN INCBIIB | 23 funds | $413.9M |
| RELAY THERAPEUTICS INCRLAY | 23 funds | $142.1M |
| C4 THERAPEUTICS INCCCCC | 23 funds | $51.9M |
| NVIDIA CORPNVDA | 22 funds | $30.5B |
| AMAZON.COM INCAMZN | 22 funds | $15.8B |
| COSTCO WHOLESALE CORPCOST | 22 funds | $4.5B |
| ADVANCED MICRO DEVICESAMD | 22 funds | $3.6B |
| LAM RESEARCH CORPLRCX | 22 funds | $3.1B |
Ranked by how many of PRLD's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Apr 21, 2026 | Bonita David P | Director, 10% Owner | Buy (P) | 1.7M | $7.5M |
| Apr 21, 2026 | Bonita David P | Director, 10% Owner | Buy (P) | 1.1M | $5.0M |
| Apr 21, 2026 | ORBIMED ADVISORS LLC | Director, 10% Owner | Buy (P) | 1.7M | $7.5M |
| Apr 21, 2026 | ORBIMED ADVISORS LLC | Director, 10% Owner | Buy (P) | 1.1M | $5.0M |
| Mar 25, 2025 | Vaddi Krishna | CEO, Director | Buy (P) | 675K | $466K |
| Mar 25, 2025 | Combs Andrew | Chief Chemistry Officer | Buy (P) | 100K | $69K |
| Mar 21, 2025 | Vaddi Krishna | CEO, Director | Buy (P) | 15K | $11K |
| Mar 20, 2025 | Vaddi Krishna | CEO, Director | Buy (P) | 5K | $4K |
| Mar 17, 2025 | Vaddi Krishna | CEO, Director | Buy (P) | 9K | $7K |
| Mar 14, 2025 | Vaddi Krishna | CEO, Director | Buy (P) | 30K | $22K |
| Mar 13, 2025 | Vaddi Krishna | CEO, Director | Buy (P) | 50K | $36K |
| Mar 12, 2025 | Vaddi Krishna | CEO, Director | Buy (P) | 48K | $34K |
Connected entities for PRLD
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/PRLD/capital-change-brief"
Use Arkolith's capital_change_brief for PRLD. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for PRLD. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.